Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2417867
Max Phase: Preclinical
Molecular Formula: C19H16N4O4S
Molecular Weight: 396.43
Molecule Type: Small molecule
Associated Items:
ID: ALA2417867
Max Phase: Preclinical
Molecular Formula: C19H16N4O4S
Molecular Weight: 396.43
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(O)CNC(=O)c1ccc(NC(=S)N/N=C2/CC(=O)c3ccccc32)cc1
Standard InChI: InChI=1S/C19H16N4O4S/c24-16-9-15(13-3-1-2-4-14(13)16)22-23-19(28)21-12-7-5-11(6-8-12)18(27)20-10-17(25)26/h1-8H,9-10H2,(H,20,27)(H,25,26)(H2,21,23,28)/b22-15-
Standard InChI Key: DLQJENHDIGVBJV-JCMHNJIXSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 396.43 | Molecular Weight (Monoisotopic): 396.0892 | AlogP: 1.78 | #Rotatable Bonds: 5 |
Polar Surface Area: 119.89 | Molecular Species: ACID | HBA: 5 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 3.40 | CX Basic pKa: 0.98 | CX LogP: 1.98 | CX LogD: -1.43 |
Aromatic Rings: 2 | Heavy Atoms: 28 | QED Weighted: 0.45 | Np Likeness Score: -1.02 |
1. El-Sharief MA, Abbas SY, El-Bayouki KA, El-Bayouki KA, El-Gammal EW.. (2013) Synthesis of thiosemicarbazones derived from N-(4-hippuric acid)thiosemicarbazide and different carbonyl compounds as antimicrobial agents., 67 [PMID:23871906] [10.1016/j.ejmech.2013.06.031] |
Source(1):